BE501336A - - Google Patents
Info
- Publication number
- BE501336A BE501336A BE501336DA BE501336A BE 501336 A BE501336 A BE 501336A BE 501336D A BE501336D A BE 501336DA BE 501336 A BE501336 A BE 501336A
- Authority
- BE
- Belgium
- Prior art keywords
- solution
- ether
- tri
- methyl alcohol
- filtered
- Prior art date
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- ASXBYYWOLISCLQ-HZYVHMACSA-N dihydrostreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O ASXBYYWOLISCLQ-HZYVHMACSA-N 0.000 description 4
- 229960002222 dihydrostreptomycin Drugs 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 3
- ASXBYYWOLISCLQ-UHFFFAOYSA-N Dihydrostreptomycin Natural products O1C(CO)C(O)C(O)C(NC)C1OC1C(CO)(O)C(C)OC1OC1C(N=C(N)N)C(O)C(N=C(N)N)C(O)C1O ASXBYYWOLISCLQ-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960004909 aminosalicylic acid Drugs 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- CZWJCQXZZJHHRH-YCRXJPFRSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O CZWJCQXZZJHHRH-YCRXJPFRSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-M 4-aminosalicylate(1-) Chemical compound NC1=CC=C(C([O-])=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-M 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- -1 amino- Chemical class 0.000 description 1
- 229960001162 dihydrostreptomycin sulfate Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE501336A true BE501336A (d) |
Family
ID=143184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE501336D BE501336A (d) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE501336A (d) |
-
0
- BE BE501336D patent/BE501336A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE501336A (d) | ||
Jacobs et al. | Syntheses in the Cinchona Series. II. Quaternary Salts. | |
RU2788165C1 (ru) | Способ получения 4-хлорфталевой кислоты | |
CN115850056B (zh) | 一种布洛芬l-赖氨酸盐的制备方法 | |
US4228081A (en) | Separation of isomers | |
BE441314A (d) | ||
JPS58172365A (ja) | S−(カルボキシメチル)−(r)−システイン及びs−(カルボキシメチル)−(s)−システインの収得法 | |
BE501232A (d) | ||
BE542228A (d) | ||
BE511219A (d) | ||
SU169503A1 (ru) | Способ получения 2,4-динитростирола | |
BE628258A (d) | ||
CH294337A (fr) | Procédé de préparation d'un amino-propanediol optiquement actif. | |
WO2015070995A1 (en) | Process for the preparation of enatiomerically pure 1-aminoindan | |
BE827580A (fr) | Preparation de d et l-2-amino-1-butanol | |
BE529378A (d) | ||
CH370093A (fr) | Procédé pour la préparation de dérivés de l'acide diamino-caproïque | |
BE444052A (d) | ||
BE560575A (d) | ||
BE522289A (d) | ||
BE547321A (d) | ||
BE515059A (d) | ||
BE548447A (d) | ||
CH448126A (fr) | Procédé de préparation de sels de l'acide paradihydroxy-benzène-sulfonique | |
CH338197A (fr) | Procédé d'obtention de peptides |